Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Antony William, Raoul Verma-Fuehring, Sophia Kuehnel, Dorothee Schwabe, Daniel Kampik, Winfried Goebel & Jost Hillenkamp. (2023) Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes. Clinical Ophthalmology 17, pages 769-777.
Read now
Read now
Aumer Shughoury, Duriye D. Sevgi & Thomas A. Ciulla. (2023) The complement system: a novel therapeutic target for age-related macular degeneration. Expert Opinion on Pharmacotherapy 24:17, pages 1887-1899.
Read now
Read now
Anne Macnamara, Celia S. Chen, Andrew Davies, Charlotte Sloan & Tobias Loetscher. (2023) Low vision devices for age-related macular degeneration: a systematic review. Disability and Rehabilitation: Assistive Technology 18:7, pages 998-1010.
Read now
Read now
Orly Weinstein, Arnon D. Cohen, Jaime Levy, Ofira Zloto, Tamar Freud, Israel Krieger, Doron Comaneshter & Rachel Shemesh. (2023) Anxiety in Patients with Neovascular Age-related Macular Degeneration. Ophthalmic Epidemiology 30:3, pages 286-292.
Read now
Read now
Andrew Chang, John Stokes, Lindy Priestman, Connor Holmes & Peter Said. (2021) Impact of a Patient Support Program on Patient Beliefs About Neovascular Age-Related Macular Degeneration and Persistence to Anti-Vascular Endothelial Growth Factor Therapy. Patient Preference and Adherence 15, pages 511-521.
Read now
Read now
Bianka Sobolewska, Muhammed Sabsabi & Focke Ziemssen. (2021) Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration. Clinical Ophthalmology 15, pages 4317-4326.
Read now
Read now
Ellie Bowditch, Eugenia Chu, Thomas Hong & Andrew A. Chang. (2021) Treat and extend paradigm in management of neovascular age-related macular degeneration: current practice and future directions. Expert Review of Ophthalmology 16:4, pages 267-286.
Read now
Read now
Praveen J Patel, Focke Ziemssen, Eugene Ng, Anushini Muthutantri, David Silverman, Elizabeth A Tschosik & Ronald A Cantrell. (2020) Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use. Clinical Ophthalmology 14, pages 15-28.
Read now
Read now
Kimberly L Spooner, Gerry Guinan, Saskia Koller, Thomas Hong & Andrew A Chang. (2019) Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia. Diabetes, Metabolic Syndrome and Obesity 12, pages 1913-1921.
Read now
Read now
Articles from other publishers (35)
Justus G. Garweg, Claudine A. Blum, René-Pierre Copt, Chiara M. Eandi, Katja Hatz, Christian F. Prünte, Eleonora Seelig & Gábor M. Somfai. (2023) Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects. Ophthalmology and Therapy 12:2, pages 639-655.
Crossref
Crossref
Richard P. Gale, Robert P. Finger, Bora Eldem, Tariq Aslam, Jane Barratt, Vincent Daien, Laurent Kodjikian, Anat Loewenstein, Mali Okada, Tien Yin Wong, Michelle Sylvanowicz & Francisco J. Rodríguez. (2022) The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden. Acta Ophthalmologica 101:1.
Crossref
Crossref
Raffael G. Liegl, Helene Karcher, Shala Chetty-Mhlanga, Franklin Igwe & Rita Freitas. (2022) The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data. Ophthalmology and Therapy 12:1, pages 195-208.
Crossref
Crossref
Xuan Cao, Jaron Castillo Sanchez, Tapan P. Patel, Zhiyong Yang, Chuanyu Guo, Danyal Malik, Anuoluwapo Sopeyin, Silvia Montaner & Akrit Sodhi. (2023) Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab. Journal of Clinical Investigation 133:2.
Crossref
Crossref
Jae Hui Kim, Min Sagong, Se Joon Woo, Yu Cheol Kim, Heeyoon Cho, Young Hoon Lee, Iksoo Byon, Young Joon Jo, Hee Seung Chin, Youkyung Lee, Jae Eun Chae & Se Woong Kang. (2022) A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea. Scientific Reports 12:1.
Crossref
Crossref
Hatice TÜRKER ASLAN & Ömer ATEŞ. (2022) INVESTIGATION OF LEVEL OF SERUM INTERLEUKİN 17 IN AGE-RELATED MACULAR DEGENERATİON. Sabuncuoglu Serefeddin Health Sciences.
Crossref
Crossref
Michel Giunta, Louis-Pierre Gauvin Meunier, Donald Nixon, Jeff Steeves & Jason Noble. (2022) Early Canadian Real-World Experience with Brolucizumab in Anti-Vascular Endothelial Growth Factor-Experienced Patients with Neovascular Age-Related Macular Degeneration: A Retrospective Chart Review. Clinical Ophthalmology Volume 16, pages 2885-2894.
Crossref
Crossref
Aumer Shughoury, Duriye Damla Sevgi & Thomas A. Ciulla. (2022) Molecular Genetic Mechanisms in Age-Related Macular Degeneration. Genes 13:7, pages 1233.
Crossref
Crossref
Yu Qin, Aumreetam Dinabandhu, Xuan Cao, Jaron Castillo Sanchez, Kathleen Jee, Murilo Rodrigues, Chuanyu Guo, Jing Zhang, Jordan Vancel, Deepak Menon, Noore-Sabah Khan, Tao Ma, Stephany Y. Tzeng, Yassine Daoud, Jordan J. Green, Gregg L. Semenza, Silvia Montaner & Akrit Sodhi. (2022) ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization. JCI Insight 7:13.
Crossref
Crossref
Xinxin Zhao, Ivan Seah, Kun Xue, Wendy Wong, Queenie Shu Woon Tan, Xiaoxiao Ma, Qianyu Lin, Jason Y. C. Lim, Zengping Liu, Bhav Harshad Parikh, Karishma N. Mehta, Joel Weijia Lai, Binxia Yang, Kim Chi Tran, Veluchamy Amutha Barathi, Kang Hao Cheong, Walter Hunziker, Xinyi Su & Xian Jun Loh. (2021) Antiangiogenic Nanomicelles for the Topical Delivery of Aflibercept to Treat Retinal Neovascular Disease. Advanced Materials 34:25, pages 2108360.
Crossref
Crossref
Anthony P. Adamis & Eugene de Juan. (2022) Development of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration. Current Opinion in Ophthalmology 33:3, pages 131-136.
Crossref
Crossref
Assaf Ben-Arzi, Rita Ehrlich & Ron Neumann. (2022) Retinal Diseases: The Next Frontier in Pharmacodelivery. Pharmaceutics 14:5, pages 904.
Crossref
Crossref
Daiana Roxana Pur, Arshpreet Bassi & Monali S. Malvankar-Mehta. (2022) Impact on caregivers of patients with eye diseases: systematic review and meta-analysis. Canadian Journal of Ophthalmology.
Crossref
Crossref
Ana Patricia Marques, Jacqueline Ramke, John Cairns, Thomas Butt, Justine H. Zhang, Iain Jones, Marty Jovic, Allyala Nandakumar, Hannah Faal, Hugh Taylor, Andrew Bastawrous, Tasanee Braithwaite, Serge Resnikoff, Peng T. Khaw, Rupert Bourne, Iris Gordon, Kevin Frick & Matthew J. Burton. (2022) The economics of vision impairment and its leading causes: A systematic review. eClinicalMedicine 46, pages 101354.
Crossref
Crossref
Sara Llorente‐González, Maria Hernandez, Jorge González‐Zamora, Valentina Bilbao‐Malavé, Patricia Fernández‐Robredo, Manuel Saenz‐de‐Viteri, Jesús Barrio‐Barrio, María José Rodríguez‐Cid, Juan Donate, Francisco J. Ascaso, Ana M. Gómez‐Ramírez, Javier Araiz, Félix Armadá, Óscar Ruiz‐Moreno, Sergio Recalde, Alfredo García‐Layana, Elena Alonso, Ángel Salinas‐Alamán, Jaione Bezunartea, Maximino J. Abraldes, Marta Díez‐Sotelo, María Teresa Sarandeses‐Díez, María Dolores Taboada‐Gago, María Knight Asorey, Alicia Valverde‐Megías, Gema Felipe‐Marquez, Ana Honrubia‐Grijalbo, María Esther Núñez‐Benito, José J Escobar‐Barranco, Begoña Pina‐Marín, Manel Fernández‐Bonet, Yolanda Jadraque‐Ruíz, Jaume Crespi, Eva García‐Parès, Esther Mingorance‐Moya, Francisca Bassaganyas‐Vilarrassa, Javier Sambricio, Beatriz de‐Lucas‐Viejo, Luis Arias‐Barquet, Mercè Badia‐Vera, Pablo Gili‐Manzanaro, Leyre Lloreda‐Martín, Martim Azevedo González‐Oliva, Rosario Cobo‐Soriano, Jesús Zarallo‐Gallardo, Inmaculada Lozano‐Escobar, María del Pino Cidad‐Betegón, Javier Coca‐Robinot, Oriana D’Anna‐Mardero, Silvia Méndez‐Martínez, Nieves Pardiñas‐Barón, María Rocío Gil‐Ruiz, Patricia Udaondo, Ana I Catalá‐Gregori, Lucía Ramos‐González, Jorge Vila‐Arteaga, Isabel Gómez‐Ledesma, Javier Zarranz‐Ventura, Anna Sala‐Puigdollers, Noelia Sabater‐Cruz, Carolina Bernal‐Morales, Marc Figueras‐Roca, Juan J Marín‐Méndez & Onintza Sayar. (2021) The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age‐related macular degeneration long‐term treated in real world. Acta Ophthalmologica 100:2.
Crossref
Crossref
Xuan Cao, Jaron Castillo Sanchez, Aumreetam Dinabandhu, Chuanyu Guo, Tapan P. Patel, Zhiyong Yang, Ming-Wen Hu, Lijun Chen, Yuefan Wang, Danyal Malik, Kathleen Jee, Yassine J. Daoud, James T. Handa, Hui Zhang, Jiang Qian, Silvia Montaner & Akrit Sodhi. (2022) Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy. Journal of Clinical Investigation 132:2.
Crossref
Crossref
Begoña Pina Marín, Nuria María Gajate Paniagua, Laia Gómez-Baldó & Roberto Gallego-Pinazo. (2021) Burden of disease assessment in patients with neovascular age-related macular degeneration in Spain: Results of the AMD-MANAGE study. European Journal of Ophthalmology 32:1, pages 385-394.
Crossref
Crossref
Michael Singer, Arshad M. Khanani, Armin Wolf, Rita Flores, Jay Chhablani, Guruprasad B, Andreas Clemens, Kinfemichael Gedif, Xiaoxi Liu, Zufar Mulyukov & Giuseppe Querques. (2022) Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials. Ophthalmologica 245:4, pages 315-322.
Crossref
Crossref
Frank G. Holz, Piotr Oleksy, Federico Ricci, Peter K. Kaiser, Joachim Kiefer & Steffen Schmitz-Valckenberg. (2022) Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology 129:1, pages 54-63.
Crossref
Crossref
Dionysis D. Balatsoukas, Konstantinos T. Tsaousis, Konstadinos G. Boboridis, Anastasios G. Konstas & Fotis Topouzis. (2021) Emerging Treatment Modalities for Neovascular Age-Related Macular Degeneration: A Systematic Overview. Advances in Therapy 39:1, pages 5-32.
Crossref
Crossref
Ling Yeung, Yi-Ting Hsieh, Chang-Hao Yang, Lee-Jen Chen, Shih-Jen Chen, Cheng-Kuo Cheng, Shwu-Jiuan Sheu, Ching-Yao Tsai, Tsung-Tien Wu, Wei-Chi Wu & San-Ni Chen. (2021) Management of neovascular age-related macular degeneration: Taiwan expert consensus. Journal of the Formosan Medical Association 120:12, pages 2061-2071.
Crossref
Crossref
Harshil Dharamdasani Detaram, Gerald Liew, Joshua R. Lewis, Nicola P. Bondonno, Catherine P. Bondonno, Kim Van Vu, George Burlutsky, Jonathan M. Hodgson, Paul Mitchell & Bamini Gopinath. (2021) Dietary flavonoids are associated with longitudinal treatment outcomes in neovascular age-related macular degeneration. European Journal of Nutrition 60:8, pages 4243-4250.
Crossref
Crossref
Arghavan AlmonyKatelyn R KeylounBijal Shah-ManekJasjit K MultaniCatherine B McGuinessChi-Chang ChenJoanna H Campbell. (2021) Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysis. Journal of Managed Care & Specialty Pharmacy 27:9, pages 1260-1272.
Crossref
Crossref
J.I. Fernández-Vigo, B. Burgos-Blasco, C. Calvo-González, M.J. Escobar-Moreno, H. Shi, M. Jiménez-Santos, A. Valverde-Megías, J. Reche-Frutos, L. López-Guajardo & J. Donate-López. (2021) Assessment of vision-related quality of life and depression and anxiety rates in patients with neovascular age-related macular degeneration. Archivos de la Sociedad Española de Oftalmología (English Edition) 96:9, pages 470-475.
Crossref
Crossref
J.I. Fernández-Vigo, B. Burgos-Blasco, C. Calvo-González, M.J. Escobar-Moreno, H. Shi, M. Jiménez-Santos, A. Valverde-Megías, J. Reche-Frutos, L. López-Guajardo & J. Donate-López. (2021) Evaluación de la calidad de vida y la presencia de síntomas de depresión y ansiedad en pacientes con degeneración macular asociada a la edad neovascular. Archivos de la Sociedad Española de Oftalmología 96:9, pages 470-475.
Crossref
Crossref
Fumi Gomi, Reiko Toyoda, Annabelle Hein Yoon & Kota Imai. (2021) Factors of Anti-Vascular Endothelial Growth Factor Therapy Withdrawal in Patients with Neovascular Age-Related Macular Degeneration: Implications for Improving Patient Adherence. Journal of Clinical Medicine 10:14, pages 3106.
Crossref
Crossref
Rishi P. Singh, Justin S. Yu, Guruprasad B & Neetu Agashivala. (2021) Anti-VEGF Treatment Patterns in Patients With Wet Age-Related Macular Degeneration in Clinical Practice. Ophthalmic Surgery, Lasers and Imaging Retina 52:5, pages 263-272.
Crossref
Crossref
E. V. Bobykin, V. Y. Krokhalev, R. V. Buslaev & O. V. Morozova. (2021) Factors determining the compliance of patients receiving anti-VEGF therapy for macular diseases with long-term follow-up in real-life practice. Russian Ophthalmological Journal 14:1, pages 21-29.
Crossref
Crossref
Mali Okada, Paul Mitchell, Robert P. Finger, Bora Eldem, S. James Talks, Ceri Hirst, Luciano Paladini, Jane Barratt, Tien Yin Wong & Anat Loewenstein. (2021) Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology 128:2, pages 234-247.
Crossref
Crossref
Jian Lee Yeong, Emma Loveman, Jill L Colquitt, Pamela Royle, Norman Waugh & Noemi Lois. (2020) Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Harshil Dharamdasani Detaram, Gerald Liew, Joanna Russell, Kim Van Vu, George Burlutsky, Paul Mitchell & Bamini Gopinath. (2020) Dietary antioxidants are associated with presence of intra‐ and sub‐retinal fluid in neovascular age‐related macular degeneration after 1 year. Acta Ophthalmologica 98:7.
Crossref
Crossref
Alvin Wei Jun Teo, Tyler Hyungtaek Rim, Chee Wai Wong, Andrew Shih Hsiang Tsai, Nazurah Loh, Thiyagarajan Jayabaskar, Tien Yin Wong, Chui Ming Gemmy Cheung & Ian Yew San Yeo. (2020) Design, implementation, and evaluation of a nurse-led intravitreal injection programme for retinal diseases in Singapore. Eye 34:11, pages 2123-2130.
Crossref
Crossref
Kelvin Yi Chong Teo, Nakul Saxena, Alfred Gan, Tien Y. Wong, Mark C. Gillies, Usha Chakravarthy & Chui Ming Gemmy Cheung. (2020) Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration. Ophthalmology Retina 4:9, pages 871-880.
Crossref
Crossref
Ivan Seah, Xinxin Zhao, Qianyu Lin, Zengping Liu, Steven Zheng Zhe Su, Yew Sen Yuen, Walter Hunziker, Gopal Lingam, Xian Jun Loh & Xinyi Su. (2020) Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases. Eye 34:8, pages 1341-1356.
Crossref
Crossref
Shaun Jackson & John P. Stokes. (2020) Impact of out‐of‐pocket costs on patient initiation, adherence and persistence rates for patients treated with anti‐vascular endothelial growth factor medicines. Clinical & Experimental Ophthalmology 48:4, pages 477-485.
Crossref
Crossref